Anti-CYFIP1 antibody (980-1060 aa) (STJ191750)

SKU:
STJ191750

Current Stock:
Host: Rabbit
Applications: WB/ELISA
Reactivity: Human/Rat/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Cytoplasmic FMR1-interacting protein 1 (980-1060 aa) is suitable for use in Western Blot and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-2000
ELISA 1:5000-20000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: CYFIP1
Gene ID: 23191
Uniprot ID: CYFP1_HUMAN
Immunogen Region: 980-1060 aa
Specificity: CYFP1 Polyclonal Antibody detects endogenous levels of protein.
Immunogen: Synthesized peptide derived from the human protein at the amino acid range 980-1060
Protein Name Cytoplasmic Fmr1-Interacting Protein 1
Specifically Rac1-Associated Protein 1
Sra-1
P140sra-1
Database Links Reactome: R-HSA-2029482
Reactome: R-HSA-4420097
Reactome: R-HSA-5663213
Reactome: R-HSA-6798695
Reactome: R-HSA-9013149
Reactome: R-HSA-9013404
Reactome: R-HSA-9013408
Reactome: R-HSA-9013423
Reactome: R-HSA-9664422
Cellular Localisation Cytoplasm
Perinuclear Region
Cell Projection
Lamellipodium
Ruffle
Synapse
Synaptosome
Highly Expressed In The Perinuclear Region
Enriched In Synaptosomes
Also Enriched In Membrane Ruffles And At The Tips Of Lamellipodia
Alternative Antibody Names Anti-Cytoplasmic Fmr1-Interacting Protein 1 antibody
Anti-Specifically Rac1-Associated Protein 1 antibody
Anti-Sra-1 antibody
Anti-P140sra-1 antibody
Anti-CYFIP1 antibody
Anti-KIAA0068 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance